Dec 06, 2013 03:48 PM IST
Dheeraj Aggarwal, CFO, Venus Remedies is especially ecstatic about bagging the marketing rights for Meropenem in Gulf, Saudi Arabia as the company would be the first generic player there.
May 08, 2013 04:47 PM IST
Venus Remedies entered OTC (over-the-counter) category with Ezenus. Dheeraj Aggarwal, CFO, Venus Remedies says that Ezenus is our first OTC product which is a stress reliever. It works for reducing anti-toxicants in the body.
Mar 25, 2013 04:14 PM IST
Dheeraj Aggarwal, CFO, Venus Remedies, speaking to CNBC-TV18 on the occasion of the company's first ever over-the-counter (OTC) stress reliving drug launch, said that it is a unique product with no competition.